‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study Source: Annual Congress 2011 - Asthma management and response Year: 2011
The influence of smoking on the treatment response in patients with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007
Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Impact of age, age at diagnosis and duration of asthma on the risk of exacerbations in the EuroSMART study Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012
Impact of onset time in patients with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003
Impact of omalizumab treatment persistence on asthma control Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Has the sex ratio for prevalence of asthma and allergies changed over time? Source: Eur Respir J 2001; 18: Suppl. 33, 154s Year: 2001
Relationship between time of the first exacerbation of childhood asthma and asthma prognosis at the age of 30 Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
The effect of passive smoking on severity of children asthma Source: Eur Respir J 2001; 18: Suppl. 33, 453s Year: 2001
Heterogeneity and time course of asthma exacerbations: data from AUSTRI Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021
A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use Source: Eur Respir J 2016; 48: 726-733 Year: 2016
Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
Cough variant asthma: prevalence and outcome of specific therapy Source: Eur Respir J 2004; 24: Suppl. 48, 589s Year: 2004
Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 7s Year: 2005
The effect of smoking on lung function: a clinical study of adult-onset asthma Source: Eur Respir J 2016; 48: 1298-1306 Year: 2016
Asthma in adults: association of asthma symptoms and age at asthma diagnosis Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020
Are there sub groups of children with asthma where FeNO guided treatment is associated with reduced risk for asthma attacks? Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017
Are a degree of asthma therapy related to asthma control impairment? Source: Eur Respir J 2003; 22: Suppl. 45, 370s Year: 2003